Results 11 to 20 of about 36,482,451 (268)

Using smartphone sensors for ataxia trials: consensus guidance by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers [PDF]

open access: yes, 2023
Smartphone sensors are used increasingly in the assessment of ataxias. To date, there is no specific consensus guidance regarding a priority set of smartphone sensor measurements, or standard assessment criteria that are appropriate for clinical trials ...
Dukart, Juergen   +2 more
core   +1 more source

Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges. [PDF]

open access: yes, 2012
New proposed criteria for the clinical diagnosis of Alzheimer's disease increasingly incorporate biomarkers, most of which are normally measured on a continuous scale. Operationalizing such criteria thus requires continuous biomarkers to be dichotomized,
Skillbäck, Tobias,   +10 more
core   +1 more source

Emerging Biomarkers for Immunotherapy in Glioblastoma

open access: yes, 2022
Immunotherapy has shown clinical benefits in several solid malignancies—in particular, melanoma and non-small cell lung cancer. However, in other solid tumours such as glioblastoma (GBM), the response to immunotherapy has been more variable, and ...
Nadia Mensali, Else Marit Inderberg
core   +1 more source

Biomarkers and Lung Cancer Early Detection: State of the Art

open access: yes, 2021
Lung cancer burden is increasing, with 2 million deaths/year worldwide. Current limitations in early detection impede lung cancer diagnosis when the disease is still localized and thus more curable by surgery or multimodality treatment.
Fabrizio Bianchi   +6 more
core   +1 more source

The Current Landscape of Glioblastoma Biomarkers in Body Fluids

open access: yes, 2023
Glioblastoma (GBM) is a highly aggressive and lethal primary brain cancer that necessitates early detection and accurate diagnosis for effective treatment and improved patient outcomes.
Mohammad Doroudian   +5 more
core   +1 more source

Serum-Exosome-Derived miRNAs Serve as Promising Biomarkers for HCC Diagnosis

open access: yes, 2022
Background: Serum exosomes are emerging as key liquid biopsy biomarkers for the early diagnosis of cancer. However, the proportion and distribution of small RNA (sRNA) species from serum exosomes of hepatocellular carcinoma (HCC) patients remain unclear.
Ning Tang   +6 more
core   +1 more source

The Detection of Vancomycin in Sweat: A Next-Generation Digital Surrogate Marker for Antibiotic Tissue Penetration: A Pilot Study

open access: yesDigital Biomarkers, 2021
Background: Assuring adequate antibiotic tissue concentrations at the point of infection, especially in skin and soft tissue infections, is pivotal for an effective treatment and cure.
Noé Brasier   +10 more
doaj   +1 more source

Usable Data Visualization for Digital Biomarkers: An Analysis of Usability, Data Sharing, and Clinician Contact

open access: yesDigital Biomarkers, 2022
Background: While digital phenotyping smartphone apps can collect vast amounts of information on participants, less is known about how these data can be shared back.
Luke Scheuer, John Torous
doaj   +1 more source

Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat [PDF]

open access: yes, 2012
Improved biomarkers of acute nephrotoxicity are coveted by the drug development industry, regulatory agencies, and clinicians. In an effort to identify such biomarkers, urinary peptide profiles of rats treated with two different nephrotoxins were ...
Hanig, J.   +23 more
core   +2 more sources

Pathological Digital Biomarkers: Validation and Application

open access: yes, 2022
Digital pathology offers powerful tools for biomarker discovery, analysis, and translation. Despite its advantages, the clinical adoption of digital pathology has been slow.
Youngjae Song   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy